Succinic Acid

Succinic Acid

SCHEMBL507455

O=C(O)CCC(=O)O.O=C(c1ccc(CSc2c(Cl)ccc3c2CCNCC3)nc1)N(F)Cc1ccc(C(F)(F)F)cc1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 1/20 0.35
HTR2B P41595 1/20 0.35
TRPM8 Q7Z2W7 7/20 0.34
RORC P51449 1/20 0.31
GCGR P47871 2/20 0.31
GIPR P48546 2/20 0.31
PPARD Q03181 2/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
PDK1 Q15118 1/20 0.30
EGLN1 Q9GZT9 1/20 0.30
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
CETP P11597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10476152 0.96 HTR2C (0.37) HTR2CHTR2BTRPM8RORCMEN1
Succinic Acid SCHEMBL4247899 0.91 TRPM8 (0.33) HTR2CHTR2BTRPM8RORCGCGR
Succinic Acid SCHEMBL507972 0.90 PPARD (0.35) HTR2CHTR2BTRPM8GCGRGIPR
SCHEMBL10476165 0.86 HTR2C (0.37) HTR2CHTR2BTRPM8PPARDMEN1
SCHEMBL507567 0.81 RORC (0.36) RORCCETP
Succinic Acid SCHEMBL507454 0.79 RORC (0.36) RORCGCGR
Succinic Acid SCHEMBL507783 0.79 HTR2C (0.36) HTR2CHTR2B
Succinic Acid SCHEMBL508440 0.78 RXFP1 (0.38) PPARG
Succinic Acid SCHEMBL507048 0.77 CHEK1 (0.35) HTR2CHTR2B
SCHEMBL10476305 0.77 HTR2C (0.36) HTR2CHTR2BPPARDPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580780-B2 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist ELI LILLY AND COMPANY (US) 2013-11-12 US disclosed
EP-2479168-A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists ELI LILLY AND COMPANY (US) 2012-07-25 EP disclosed
US-20120028961-A1 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist ELI LILLY AND COMPANY (US) 2012-02-02 US disclosed
US-8022062-B2 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists ELI LILLY AND COMPANY (US) 2011-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028961-A1 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist HTR2C, HTR4, HTR1A HTR2C 1/4885HTR2B 12/4885TRPM8 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.